Reply
Hepatology
.
2018 Feb;67(2):803-804.
doi: 10.1002/hep.29674.
Epub 2018 Jan 2.
Authors
Bruce Wang
1
,
Manisha Balwani
2
,
Herbert L Bonkovsky
3
,
Karl E Anderson
4
,
Joseph R Bloomer
5
,
D Montgomery Bissell
1
,
John D Phillips
6
,
Robert J Desnick
2
;
Porphyrias Consortium of the Rare Diseases Clinical Research Network
Affiliations
1
Department of Medicine, University of California, San Francisco, CA.
2
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
3
Department of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC.
4
Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, TX.
5
Department of Medicine, University of Alabama, Birmingham, AL.
6
Department of Internal Medicine, University of Utah, Salt Lake City, UT.
PMID:
29159969
DOI:
10.1002/hep.29674
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Porphobilinogen Synthase
Porphyrias, Hepatic*
Substances
Porphobilinogen Synthase